Cargando…

Evidence supporting a role for N(ε)-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy

PURPOSE: Recent evidence suggests that neuroglial dysfunction and degeneration contributes to the etiology and progression of diabetic retinopathy. Advanced lipoxidation end products (ALEs) have been implicated in the pathology of various diseases, including diabetes and several neurodegenerative di...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Phaik Har, Zong, Hongliang, Medina, Reinhold J., Limb, G. Astrid, Uchida, Koji, Stitt, Alan W., Curtis, Tim M.
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000235/
https://www.ncbi.nlm.nih.gov/pubmed/21151599
_version_ 1782193519217082368
author Yong, Phaik Har
Zong, Hongliang
Medina, Reinhold J.
Limb, G. Astrid
Uchida, Koji
Stitt, Alan W.
Curtis, Tim M.
author_facet Yong, Phaik Har
Zong, Hongliang
Medina, Reinhold J.
Limb, G. Astrid
Uchida, Koji
Stitt, Alan W.
Curtis, Tim M.
author_sort Yong, Phaik Har
collection PubMed
description PURPOSE: Recent evidence suggests that neuroglial dysfunction and degeneration contributes to the etiology and progression of diabetic retinopathy. Advanced lipoxidation end products (ALEs) have been implicated in the pathology of various diseases, including diabetes and several neurodegenerative disorders. The purpose of the present study was to investigate the possible link between the accumulation of ALEs and neuroretinal changes in diabetic retinopathy. METHODS: Retinal sections obtained from diabetic rats and age-matched controls were processed for immunohistochemistry using antibodies against several well defined ALEs. In vitro experiments were also performed using a human Müller (Moorfields/Institute of Ophthalmology-Müller 1 [MIO-M1]) glia cell line. Western blot analysis was used to measure the accumulation of the acrolein-derived ALE adduct Nε-(3-formyl-3,4-dehydropiperidino)lysine (FDP-lysine) in Müller cells preincubated with FDP-lysine-modified human serum albumin (FDP-lysine-HSA). Responses of Müller cells to FDP-lysine accumulation were investigated by analyzing changes in the protein expression of heme oxygenase-1 (HO-1), glial fibrillary acidic protein (GFAP), and the inwardly rectifying potassium channel Kir4.1. In addition, mRNA expression levels of vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), and tumor necrosis factor-α (TNFα) were determined by reverse transcriptase PCR (RT–PCR). Apoptotic cell death was evaluated by fluorescence-activated cell sorting (FACS) analysis after staining with fluorescein isothiocyanate (FITC)-labeled annexin V and propidium iodide. RESULTS: No significant differences in the levels of malondialdehyde-, 4-hydroxy-2-nonenal-, and 4-hydroxyhexenal-derived ALEs were evident between control and diabetic retinas after 4 months of diabetes. By contrast, FDP-lysine immunoreactivity was markedly increased in the Müller glia of diabetic rats. Time-course studies revealed that FDP-lysine initially accumulated within Müller glial end feet after only a few months of diabetes and thereafter spread distally throughout their inner radial processes. Exposure of human Müller glia to FDP-lysine-HSA led to a concentration-dependent accumulation of FDP-lysine-modified proteins across a broad molecular mass range. FDP-lysine accumulation was associated with the induction of HO-1, no change in GFAP, a decrease in protein levels of the potassium channel subunit Kir4.1, and upregulation of transcripts for VEGF, IL-6, and TNF-α. Incubation of Müller glia with FDP-lysine-HSA also caused apoptosis at high concentrations. CONCLUSIONS: Collectively, these data strongly suggest that FDP-lysine accumulation could be a major factor contributing to the Müller glial abnormalities occurring in the early stages of diabetic retinopathy.
format Text
id pubmed-3000235
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-30002352010-12-13 Evidence supporting a role for N(ε)-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy Yong, Phaik Har Zong, Hongliang Medina, Reinhold J. Limb, G. Astrid Uchida, Koji Stitt, Alan W. Curtis, Tim M. Mol Vis Research Article PURPOSE: Recent evidence suggests that neuroglial dysfunction and degeneration contributes to the etiology and progression of diabetic retinopathy. Advanced lipoxidation end products (ALEs) have been implicated in the pathology of various diseases, including diabetes and several neurodegenerative disorders. The purpose of the present study was to investigate the possible link between the accumulation of ALEs and neuroretinal changes in diabetic retinopathy. METHODS: Retinal sections obtained from diabetic rats and age-matched controls were processed for immunohistochemistry using antibodies against several well defined ALEs. In vitro experiments were also performed using a human Müller (Moorfields/Institute of Ophthalmology-Müller 1 [MIO-M1]) glia cell line. Western blot analysis was used to measure the accumulation of the acrolein-derived ALE adduct Nε-(3-formyl-3,4-dehydropiperidino)lysine (FDP-lysine) in Müller cells preincubated with FDP-lysine-modified human serum albumin (FDP-lysine-HSA). Responses of Müller cells to FDP-lysine accumulation were investigated by analyzing changes in the protein expression of heme oxygenase-1 (HO-1), glial fibrillary acidic protein (GFAP), and the inwardly rectifying potassium channel Kir4.1. In addition, mRNA expression levels of vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), and tumor necrosis factor-α (TNFα) were determined by reverse transcriptase PCR (RT–PCR). Apoptotic cell death was evaluated by fluorescence-activated cell sorting (FACS) analysis after staining with fluorescein isothiocyanate (FITC)-labeled annexin V and propidium iodide. RESULTS: No significant differences in the levels of malondialdehyde-, 4-hydroxy-2-nonenal-, and 4-hydroxyhexenal-derived ALEs were evident between control and diabetic retinas after 4 months of diabetes. By contrast, FDP-lysine immunoreactivity was markedly increased in the Müller glia of diabetic rats. Time-course studies revealed that FDP-lysine initially accumulated within Müller glial end feet after only a few months of diabetes and thereafter spread distally throughout their inner radial processes. Exposure of human Müller glia to FDP-lysine-HSA led to a concentration-dependent accumulation of FDP-lysine-modified proteins across a broad molecular mass range. FDP-lysine accumulation was associated with the induction of HO-1, no change in GFAP, a decrease in protein levels of the potassium channel subunit Kir4.1, and upregulation of transcripts for VEGF, IL-6, and TNF-α. Incubation of Müller glia with FDP-lysine-HSA also caused apoptosis at high concentrations. CONCLUSIONS: Collectively, these data strongly suggest that FDP-lysine accumulation could be a major factor contributing to the Müller glial abnormalities occurring in the early stages of diabetic retinopathy. Molecular Vision 2010-12-02 /pmc/articles/PMC3000235/ /pubmed/21151599 Text en Copyright © 2010 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yong, Phaik Har
Zong, Hongliang
Medina, Reinhold J.
Limb, G. Astrid
Uchida, Koji
Stitt, Alan W.
Curtis, Tim M.
Evidence supporting a role for N(ε)-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy
title Evidence supporting a role for N(ε)-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy
title_full Evidence supporting a role for N(ε)-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy
title_fullStr Evidence supporting a role for N(ε)-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy
title_full_unstemmed Evidence supporting a role for N(ε)-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy
title_short Evidence supporting a role for N(ε)-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy
title_sort evidence supporting a role for n(ε)-(3-formyl-3,4-dehydropiperidino)lysine accumulation in müller glia dysfunction and death in diabetic retinopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000235/
https://www.ncbi.nlm.nih.gov/pubmed/21151599
work_keys_str_mv AT yongphaikhar evidencesupportingaroleforne3formyl34dehydropiperidinolysineaccumulationinmullergliadysfunctionanddeathindiabeticretinopathy
AT zonghongliang evidencesupportingaroleforne3formyl34dehydropiperidinolysineaccumulationinmullergliadysfunctionanddeathindiabeticretinopathy
AT medinareinholdj evidencesupportingaroleforne3formyl34dehydropiperidinolysineaccumulationinmullergliadysfunctionanddeathindiabeticretinopathy
AT limbgastrid evidencesupportingaroleforne3formyl34dehydropiperidinolysineaccumulationinmullergliadysfunctionanddeathindiabeticretinopathy
AT uchidakoji evidencesupportingaroleforne3formyl34dehydropiperidinolysineaccumulationinmullergliadysfunctionanddeathindiabeticretinopathy
AT stittalanw evidencesupportingaroleforne3formyl34dehydropiperidinolysineaccumulationinmullergliadysfunctionanddeathindiabeticretinopathy
AT curtistimm evidencesupportingaroleforne3formyl34dehydropiperidinolysineaccumulationinmullergliadysfunctionanddeathindiabeticretinopathy